Skip to main content

EUROPE GAMBLES ON HIGH TECH

In increasing numbers, European financiers are shrugging off their traditional conservatism and discovering the definition of venture capital that their U.S. cousins have always embraced taking a chance on an unproven idea or technology. To be sure, the spirit of risk taking varies from country to country—the U.K. is much more daring than West Germany, for example. But according to accounting firm Peat Marwick McLintock, last year—for the first time ever—there was more venture

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

In increasing numbers, European financiers are shrugging off their traditional conservatism and discovering the definition of venture capital that their U.S. cousins have always embraced taking a chance on an unproven idea or technology. To be sure, the spirit of risk taking varies from country to country—the U.K. is much more daring than West Germany, for example. But according to accounting firm Peat Marwick McLintock, last year—for the first time ever—there was more venture capital available in Europe then in the US. ($4.3 billion vs. $4.2 billion). And these funds are footing the bill for more and more European high-tech startups.

Entrepreneurism has long been stifeld in Europe by high taxes and a staunch aversion to risky business. “Ten years ago we did a study of young technology-based firms in the U.K. and Germany, and could find hardly any examples, recalls Kamel Saad, vice president of Arthur D. Little Inc. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Published In

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen